News
In 2010, a milestone was achieved when the first patient with cancer was treated with CAR-T-cell therapy ... decided to add the CAR gene to natural killer (NK) cells. “These cells are part ...
biologists have begun to investigate whether activating necroptosis in cancer cells could similarly coax the immune system into attacking tumors. Now, researchers show that injecting cells undergoing ...
With its breakthrough dual-targeted natural killer cell therapy platform ... effects. In cancer patients, tumor-associated macrophages (TAMs), regulatory T cells (T regs) and myeloid-derived ...
Creating cancer ... shelf cancer cell therapy given the difficulties the US system is having with the newly approved CAR-T therapies. Companies are also trying to develop natural killer-based ...
CAR-T cell therapy is a breakthrough in cancer immunotherapy. The treatment is available in India at a fraction of the cost abroad. Among the many emerging treatments for cancer, there's one called ...
It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it can affect people of any age. CAR T-cell therapy ... immune cells to stop attacking once the infection ...
Towards the final stages of diseases such as cancer and kidney disease ... In mice infected by a particular virus, killer T cells trigger the wasting of fat tissue and body weight, although how they ...
4d
Stockhead on MSNArovella tackles CAR-T’s limitations in cancer treatment with off-the-shelf innovationArovella Therapeutics at forefront of overcoming limitations of CAR-T cell therapy for cancer with its healthy donor-derived ...
In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T ... a cancer programme based on the biotech’s TriNKET natural killer (NK) cell engager ...
which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule ...
Bayer (BAYGn.DE), opens new tab was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results